Family Preservation Services, Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 22 School Street, Raven, VA 24639 Phone: 276-963-3606 Fax: 276-963-3747 |
News Archive
Reducing the risk of fractures in older women is the aim of a research study at Griffith University.
MedivirAB a research based specialty pharmaceutical company focused on infectious diseases announces that its oral, once daily investigational protease inhibitor TMC435, developed by Janssen Pharmaceuticals for the treatment of Hepatitis C virus (HCV), has commenced patient dosing and started screening in two new phase III clinical trials, HPC3001 and HPC3011, respectively.
Low-income middle-aged African-American women with high blood pressure very commonly suffer from depression and should be better screened for this serious mental health condition, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
According to British scientists a potential new drug from GlaxoSmithKline could treat mixed-lineage leukemia (MLL). MLL is the most common form of leukemia in babies. The study appeared in the journal Nature where scientists from the British drugmaker collaborating with the charity Cancer Research UK (CRUK) and Cellzome AG found that the experimental drug, called I-BET151.
Though hospitals are making strides in avoiding central line-associated blood stream infections (CLABSIs) and catheter-associated urinary tract infections (CAUTIs), a report released today, in the midst of Patient Safety Awareness Week (March 13-19), shows patients are still experiencing these serious, and sometimes fatal, infections too frequently.
› Verified 7 days ago